These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34921028)

  • 1. Association of Tumor Suppressor Sparcl1 with Clinical Staging and Prognosis of NSCLC.
    Zhou Y; Zhang Q
    Ann Clin Lab Sci; 2021 Nov; 51(6):756-765. PubMed ID: 34921028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
    Ma J; Wu K; Liu K; Miao R
    Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
    Sun QS; Luo M; Zhao HM; Sun H
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
    Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
    Kotti A; Holmqvist A; Albertsson M; Sun XF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
    Ju ZS; Sun B; Bao D; Zhang XF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
    Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
    Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARCL1 impedes trophoblast migration and invasion by down-regulating ERK phosphorylation and AP-1 production and altering EMT-related molecule expression.
    Liu X; Zhao J; Luan X; Li S; Zhai J; Liu J; Du Y
    Placenta; 2020 Jan; 89():33-41. PubMed ID: 31675488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
    Li X; Zhang Q; Fan K; Li B; Li H; Qi H; Guo J; Cao Y; Sun H
    Int J Mol Sci; 2016 Mar; 17(4):437. PubMed ID: 27023518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.